Middle East & Africa Point-of-Care Diagnostics Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (Middle East & Africa)

The point-of-care diagnostics market in the Middle East and Africa (MEA) is witnessing a strong upsurge, projected to grow from an estimated US$ 3.18 billion in 2025 to US$ 6.9 billion by 2032. The market is anticipated to register a CAGR of 11.67% during the forecast period. This growth is largely attributed to the increasing prevalence of infectious and chronic diseases, growing demand for quick diagnostic results, and significant advancements in portable and digital healthcare technologies.

________________________________________

Market Overview

The MEA point-of-care diagnostics market has evolved rapidly over recent years, reflecting a broader shift toward decentralized healthcare delivery. As healthcare systems modernize, there is a rising preference for diagnostic solutions that are accessible, rapid, and cost-effective—especially in rural and underserved areas.

Demand for point-of-care testing (POCT) is particularly high in countries like Saudi Arabia and the UAE, where healthcare modernization is a national priority. In contrast, lower-income regions in Africa face challenges such as limited healthcare spending, though international support and public-private collaborations are gradually improving access.

________________________________________

Key Drivers of Growth

1. Growing Burden of Chronic and Infectious Diseases

Chronic illnesses such as diabetes, cardiovascular diseases, and respiratory disorders are increasingly prevalent in the region due to lifestyle changes and an aging population. At the same time, infectious diseases like tuberculosis, HIV, and influenza continue to demand swift diagnosis. POCT provides the rapid results needed to manage both types of health threats effectively.

2. Demand for Rapid and Accurate Testing

Point-of-care diagnostics significantly reduce the time from testing to diagnosis, enabling timely treatment decisions. This speed is especially critical in emergencies and in remote areas where centralized laboratories are inaccessible. The demand for high-accuracy diagnostics is expected to propel adoption across hospitals, clinics, and home care settings.

3. Integration of AI and Digital Technologies

Technological advancements are enabling smarter, faster diagnostic systems. Integration of artificial intelligence and machine learning with POCT devices enhances diagnostic accuracy and provides real-time data analytics. These advancements are particularly impactful in data-scarce regions, where AI can support clinical decision-making and remote diagnostics.

________________________________________

Emerging Opportunities

1. Expansion into Remote and Rural Areas

The lack of centralized healthcare facilities in many regions creates a strong opportunity for POCT. Governments and health organizations are increasingly deploying mobile diagnostic units and portable devices to reach isolated communities. Investment in these services is expected to improve healthcare access significantly.

2. Rise of Telemedicine and Mobile Health

With the increasing use of smartphones and improved internet access, telemedicine is gaining traction. The integration of POCT with mobile health apps allows patients to access diagnostics and consult healthcare professionals remotely. This convergence is reshaping the healthcare delivery model, especially in underserved areas.

3. Product Development and Strategic Collaborations

Companies are actively investing in R&D and forming partnerships to expand their product portfolios. These strategic moves aim to offer innovative and affordable testing solutions that align with the growing healthcare needs in the region.

________________________________________

Regional Highlights

Saudi Arabia is expected to dominate the MEA point-of-care diagnostics market due to its significant investments in healthcare modernization and digital transformation. The country’s supportive government initiatives, increasing focus on preventive healthcare, and rapid infrastructure development make it a key contributor to regional growth.

The UAE also presents a promising Analysis for POCT adoption, backed by strong government focus on innovation, public-private partnerships, and expanding health-tech ecosystem.

While parts of Africa still face funding challenges, initiatives aimed at universal healthcare access and growing foreign investments in health projects are gradually uplifting the sector.

________________________________________

Market Challenges

Despite strong growth prospects, certain hurdles could hinder the broader adoption of POCT across MEA. These include:
• Low healthcare expenditure in several African nations, limiting investment in advanced diagnostic technologies.
• High initial costs associated with POCT equipment and maintenance.
• Lack of reimbursement policies, which restrict affordability for both healthcare providers and patients.
• Shortage of skilled personnel, particularly in rural areas, complicating the implementation and usage of advanced diagnostics.

________________________________________

Competitive Analysis

The MEA point-of-care diagnostics market is highly competitive, with global and regional players striving to enhance their presence. Companies are focusing on innovation, strategic collaborations, and localized production to cater to the region’s specific needs.

Key market participants include:
• QIAGEN
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• BD (Becton Dickinson)
• Abbott
• BIOMÉRIEUX
• Nova Biomedical
• Werfen
• Trividia Health, Inc.
• Siemens Healthcare Private Limited

Recent industry developments have reflected the importance of localization and collaboration. For instance, QIAGEN opened its regional headquarters in Riyadh and signed an MoU with the Saudi Ministry of Health to strengthen public health initiatives. Meanwhile, amplifAI health collaborated with USATherm to integrate thermal imaging with diagnostic tools, further enhancing disease detection capabilities.

________________________________________

Market Segmentation

By Product:
• Infectious Disease
• Glucose Monitoring
• Hepatitis C
• HIV Testing
• Sexually Transmitted Disease (STD)
• Influenza
• Respiratory Infection
• Tropical Disease
• Healthcare-Associated Infection (HAI)
• Pregnancy and Fertility
• Tumor/Cancer Marker
• Cardiometabolic
• Cholesterol
• Coagulation
• Hematology
• Urinalysis
• Other Infectious Diseases

By Prescription Mode:
• Prescription-based
• Over-the-Counter (OTC)

By Type:
• Consumables and Kits
• Software and Services
• Devices
• Accessories

By End User:
• Hospitals
• Ambulatory Care Settings
• Home Care
• Research Laboratories
• Others

By Country:
• Kingdom of Saudi Arabia
• United Arab Emirates
• South Africa
• Rest of Gulf Cooperation Council
• Rest of Middle East and Africa

Please note: Delivery Timelines - 5 working days.